*MONEY TIMES TALK* *Dated 19 February 23* *Dishman Carboge | Dr.Dumasia(Bavaji)the stock market bioscope

*MONEY TIMES TALK*
*Dated 19 February 23*

*Dishman Carbogen’s* Q3 NP rose 33% YoY to Rs.46.946 cr. led by revenue growth of 14% to Rs.640 cr. Add.

Specialty Chemicals co., *TGV SRAAC,* posted 112% higher Q3 NP YoY and may post FY23 EPS of Rs 42. It trades at a PE of just 2.92x against industry average of 47x and P/B ratio of just 1.33x against industry average of 8.72x. Strong re-rating is in store.

*NALCO* posted Q3 NP of Rs.274 cr. as against Rs.170 cr. YoY. Although profit margins was hit, it registered a robust growth in production on all fronts. Accumulate.

Although *Bharat Dynamics’* Q3 was affected due to delays in receipt of critical electronic components, it looks good as alternate sources are being evaluated. Add on dips.

*Oil India* posted its best-ever Q3 with NP of Rs.2284.41 cr. A second interim dividend of Rs.10 has also been declared. Add.

*Sarda Energy & Minerals*’ Q3 EPS fell to Rs.36.99 from Rs.46.34 YoY. The share looks attractive at a P/BV ratio of 1.20x and a PE ratio of 6.35x. Add in small quantities.

Analysts believe *M&M* may sustain its outperformance driven by consistency in the automotive and tractor divisions with higher economies of scale. Add in small quantities.

*Nykaa* PAT declined 71% YoY to Rs.8.5 cr. in Q3, in spite of a rise in revenue by 33% to Rs.1463 cr. Sell.

*Adani group* is scouting for $1.5bn of ‘confidence capital’ from Abu Dhabi Investment Authority and other major investors. Better stay away from all Adani shares for now.

Since UK faces depleting ammunition reserves given the Ukraine-Russia war, Indian defense cos. *MTAR, HAL, and Mazagon Docks Shipbuilders* must be accumulated as 75% of our armaments would be sourced from Indian companies.

Brokerage firm, Jefferies, maintains that *RIL* has a 33% upside in one year, aided by its renewable energy business and other verticals. Add for the long term.

*ITC* to export up to Rs.2000 cr. worth of raw tobacco in FY24. The other divisions of ITC are also Accumulate.

*PFC’s* Q3 NP of Rs.5241.1 cr. led to an EPS of Rs.14.76 and Rs.42.47 for 9MFY23 and a third interim dividend of Rs.3.50. An FY23 EPS of Rs.57+ and a final dividend of Rs.7+ is a distinct possibility. The share is also a bonus candidate. Buy.

*Biocon* is in talks with PE investors to sell a stake in its arm to prune its debts and fund its acquisition of Viatris Inc. The share is available at a reasonable price. Accumulate.

Packaging dynamics are changing. While *Polyplex and Cosmo Films* posted subdued results, Uflex and Jindal Polyfilms posted losses. Hold the first two and exit the other two.

*Hero MotorCorp* to boost exports to 10% of sales. Add for the long term.

*MIDHANI’s* order book stands at Rs.1400 cr., which includes 40% from the defense sector. New orders worth Rs.500+ cr. likely from MOUs signed. Add.

*Amrutanjan* is facing serious allegations of financial malpractices. It also delivered unpleasant results for Q3. Sell.

*Bharat Electronics* and Israel Aerospace Industries to manufacture its Lora weapon systems for the Indian armed forces. Positive for the company. Add.

*Shilpa Medicare* has registered its Bengaluru facility with the UAE authorities to manufacture and test its Orodispersible films and Transdermal systems. Add in small lots.

Minda Corp has acquired 15.7% stake in Pricol for Rs.400 cr. Add *Pricol* at current rates.

*Geekay* notched 226% higher Q3 EPS of Rs.5.9 and 131% higher 9M EPS of Rs.11.5 and is all set to garner FY23 EPS of Rs.16+, backed by huge demand for its products. Buy for 30% gain.

*Repco Home Finance* posted 138% higher Q3 EPS of Rs.13.3 and 51% higher 9M EPS of Rs.37.1, which may lead to FY23 EPS of Rs.47+. Buy for 30% gain.

*Karnataka Bank* has notched a 106% higher Q3 EPS of Rs.9.7 and 119% higher 9M EPS of Rs.26, which may lead to FY23 EPS of Rs.37+ as against Rs.15.5 in FY22. Buy.